- Home
- Industry Reports
- Diagnostics
- Healthcare
- Europe Head and Neck Cancer Diagnostics Market – Size, Outlook, Trends, and Forecast (2024 – 2032)
Head and Neck cancer diagnostics market deals various types of malignant tumours grown in and around head and neck which are collectively known as head and neck cancers. Most of the cancers are started in the squamous cells that line the moist mucosal surfaces of the mouth, throat, and nose identified as carcinoma. The initial points are in oral cavities, nasal cavities, larynx, salivary glands, pharynx and paranasal sinuses. Prevalence of target diseases, ageing and geriatric population, has been boosting the nuclear medicine market to handle many industries.
Europe Head and Neck Cancer Diagnostics Market Size & Growth:
Europe head and neck cancer diagnostics market is projected to reach $ 18.106 billion by 2024 with CAGR between 12 to 13% from $ 9.132 billion in 2017 during forecast 2018-2014. The critical parameters promoting the market growth are prevalence in target and chronic diseases, rise in geriatric population all over the world and healthcare initiatives by government, advancements in treatment modes and advanced diagnostic technologies and inclination in healthcare expenditure of people and so on. However, the high cost of treatment modes and lack of awareness about the cancers are hampering the market growth.
Europe Head and Neck Cancer Diagnostics Market Share:
Europe head and neck cancer diagnostics market is categorised into diagnostics imaging equipment, endoscopy screening equipment, bioscopy screening tests, blood tests and dental diagnostics methods. On the basis of diagnostic imaging, the market is categorized as PET, CT, MRI, X-RAY, and barium swallow test. This diagnostic imaging carries the significant share in the market due to the advancements in the treatment processes. On the basis of endoscopy screening equipment, the market is categorized into pharyngoscopy, laryngoscopy, and panendoscopy. Among bioscopy screening tests the market is segmented into incisional biopsy, fine needle aspiration, biopsy and HPV testing. Blood tests segment includes total cell count tests, liver function test, and EBV antibody measurement. Dental diagnostics method is based on fluorescence visualization, toluidine blue dye-based method, acetic acid rinse method and brush biopsy. On the basis of geography, Europe is segmented into France, Germany and Italy etc due to the demand in imaging diagnostics market and advancements it is believed that the market can improve the growth and propel the growth during the forecast.
Europe Head and Neck Cancer Diagnostics Market Trends:
- Philips acquired Spectranetics Corporation to accelerate the expansion of image-guided therapy devices to treat various types of cancers.
- Philips has launched new diagnostic equipment that has been developed as designed at research and development centres in India and manufactured at Pune.
- GE Healthcare and Roche diagnostics come together to develop industry-first software integrating in-vivo and in-vitro diagnostics data with latest clinical research for improved patient outcomes.
- Puridify acquired GE Healthcare and GE Healthcare provides transformational medical technologies and services.
Europe Head and Neck Cancer Diagnostics Market Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The primary market players are:
- Phillips health care
- Siemens Healthcare
- GE Healthcare
- Shimadzu Corporation
- Varian medical systems
1. Introduction
1.1. Executive Summary
1.2. Market Definition
1.3. The scope of the Study
2. Research Methodology
2.1. Secondary Research
2.2. Primary Research
2.3. Analytics Tools & Model
2.4. Economic Indicators
2.4.1.Base Year, Base Currency & Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
3. Market Analysis
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of Substitutes
3.2.4 Threat of New Entrants
3.2.5 Industry Rivalry (Competitive Environment)
3.3. PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4. SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.4.5 Y-O-Y Analysis
4. Market Dynamics
4.1. Drivers
4.1.1 Growing population worldwide.
4.1.2 Prevalence in target and chronic diseases.
4.1.3 Better government and private body initiatives.
4.2. Restraints
4.2.1 Higher costs associated with treatment modes.
4.2.2 Excise duty imposed on the sale of medical devices in mature markets.
4.3. Opportunities
4.3.1 Larger target patient pool and never-ending incomes in engineering economies.
4.4. Challenges
4.4.1 Low adoption rate of digital technology-based systems and untapped markets.
5. Europe Head and Neck Cancer Diagnostics Market – By Diagnostics methods
5.1. Diagnostics imaging equipment
5.1.1 PET/CT
5.1.2 MRI
5.1.3 X-Ray
5.1.4 Barium swallow test
5.2. Endoscopy screening equipment
5.2.1 Pharyngoscopy
5.2.2 Laryngoscopy
5.2.3 Panendoscopy
5.3. Bioscopy screening tests
5.3.1 Incisional biopsy
5.3.2 Fine needle aspiration
5.3.3 Biopsy
5.3.4 HPV testing
5.4. Blood tests
5.4.1 Total cell count tests
5.4.2 Liver function test
5.4.3 EBV antibody measurement
5.5. Dental diagnostic methods
5.5.1 Fluorescence visualisation
5.5.2 Toluidine blue dye-based method
5.5.3 Acetic acid rinse method
5.5.4 Brush biopsy
6. Europe Head and Neck Cancer Diagnostics Market – By Country
6.1. Europe
6.1.1 UK
6.1.2. Germany
6.1.3. France
6.1.4. Italy
6.1.5. Spain
6.1.6. Rest of Europe
7. Europe Head and Neck Cancer Diagnostics Market – Company Profiles
7.1 Phillips health care
7.2 Siemens healthcare
7.3 GE healthcare
7.4 Shimadzu corporation
7.5 Varian medical systems
7.6 Identafi
7.7 AdDent, Inc.
7.8 Velscope VX
8. Europe Head and Neck Cancer Diagnostics Market – Competitive Landscape
8.1 Market Share Analysis
8.2 Strategies Adopted by top companies
8.3 Mergers, Acquisitions, Collaborations & Agreements
9. Market Insights
9.1 Industry Experts Insights
9.2 Analysts Opinions
9.3 Investment Opportunities
10. Appendix
10.1 List of figures
10.2 List of figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Regional Report
$2,160.00 – $7,200.00
- EUR: €1,991.88 - €6,639.62
- INR: ₹180,043.09 - ₹600,143.64
- AED: د.إ7,927.20 - د.إ26,424.00
- GBP: £1,706.75 - £5,689.16
Description
Regional Reports
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Head and Neck cancer diagnostics market deals various types of malignant tumours grown in and around head and neck which are collectively known as head and neck cancers. Most of the cancers are started in the squamous cells that line the moist mucosal surfaces of the mouth, throat, and nose identified as carcinoma. The initial points are in oral cavities, nasal cavities, larynx, salivary glands, pharynx and paranasal sinuses. Prevalence of target diseases, ageing and geriatric population, has been boosting the nuclear medicine market to handle many industries.
Europe Head and Neck Cancer Diagnostics Market Size & Growth:
Europe head and neck cancer diagnostics market is projected to reach $ 18.106 billion by 2024 with CAGR between 12 to 13% from $ 9.132 billion in 2017 during forecast 2018-2014. The critical parameters promoting the market growth are prevalence in target and chronic diseases, rise in geriatric population all over the world and healthcare initiatives by government, advancements in treatment modes and advanced diagnostic technologies and inclination in healthcare expenditure of people and so on. However, the high cost of treatment modes and lack of awareness about the cancers are hampering the market growth.
Europe Head and Neck Cancer Diagnostics Market Share:
Europe head and neck cancer diagnostics market is categorised into diagnostics imaging equipment, endoscopy screening equipment, bioscopy screening tests, blood tests and dental diagnostics methods. On the basis of diagnostic imaging, the market is categorized as PET, CT, MRI, X-RAY, and barium swallow test. This diagnostic imaging carries the significant share in the market due to the advancements in the treatment processes. On the basis of endoscopy screening equipment, the market is categorized into pharyngoscopy, laryngoscopy, and panendoscopy. Among bioscopy screening tests the market is segmented into incisional biopsy, fine needle aspiration, biopsy and HPV testing. Blood tests segment includes total cell count tests, liver function test, and EBV antibody measurement. Dental diagnostics method is based on fluorescence visualization, toluidine blue dye-based method, acetic acid rinse method and brush biopsy. On the basis of geography, Europe is segmented into France, Germany and Italy etc due to the demand in imaging diagnostics market and advancements it is believed that the market can improve the growth and propel the growth during the forecast.
Europe Head and Neck Cancer Diagnostics Market Trends:
- Philips acquired Spectranetics Corporation to accelerate the expansion of image-guided therapy devices to treat various types of cancers.
- Philips has launched new diagnostic equipment that has been developed as designed at research and development centres in India and manufactured at Pune.
- GE Healthcare and Roche diagnostics come together to develop industry-first software integrating in-vivo and in-vitro diagnostics data with latest clinical research for improved patient outcomes.
- Puridify acquired GE Healthcare and GE Healthcare provides transformational medical technologies and services.
Europe Head and Neck Cancer Diagnostics Market Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The primary market players are:
- Phillips health care
- Siemens Healthcare
- GE Healthcare
- Shimadzu Corporation
- Varian medical systems
1. Introduction
1.1. Executive Summary
1.2. Market Definition
1.3. The scope of the Study
2. Research Methodology
2.1. Secondary Research
2.2. Primary Research
2.3. Analytics Tools & Model
2.4. Economic Indicators
2.4.1.Base Year, Base Currency & Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
3. Market Analysis
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of Substitutes
3.2.4 Threat of New Entrants
3.2.5 Industry Rivalry (Competitive Environment)
3.3. PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4. SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.4.5 Y-O-Y Analysis
4. Market Dynamics
4.1. Drivers
4.1.1 Growing population worldwide.
4.1.2 Prevalence in target and chronic diseases.
4.1.3 Better government and private body initiatives.
4.2. Restraints
4.2.1 Higher costs associated with treatment modes.
4.2.2 Excise duty imposed on the sale of medical devices in mature markets.
4.3. Opportunities
4.3.1 Larger target patient pool and never-ending incomes in engineering economies.
4.4. Challenges
4.4.1 Low adoption rate of digital technology-based systems and untapped markets.
5. Europe Head and Neck Cancer Diagnostics Market – By Diagnostics methods
5.1. Diagnostics imaging equipment
5.1.1 PET/CT
5.1.2 MRI
5.1.3 X-Ray
5.1.4 Barium swallow test
5.2. Endoscopy screening equipment
5.2.1 Pharyngoscopy
5.2.2 Laryngoscopy
5.2.3 Panendoscopy
5.3. Bioscopy screening tests
5.3.1 Incisional biopsy
5.3.2 Fine needle aspiration
5.3.3 Biopsy
5.3.4 HPV testing
5.4. Blood tests
5.4.1 Total cell count tests
5.4.2 Liver function test
5.4.3 EBV antibody measurement
5.5. Dental diagnostic methods
5.5.1 Fluorescence visualisation
5.5.2 Toluidine blue dye-based method
5.5.3 Acetic acid rinse method
5.5.4 Brush biopsy
6. Europe Head and Neck Cancer Diagnostics Market – By Country
6.1. Europe
6.1.1 UK
6.1.2. Germany
6.1.3. France
6.1.4. Italy
6.1.5. Spain
6.1.6. Rest of Europe
7. Europe Head and Neck Cancer Diagnostics Market – Company Profiles
7.1 Phillips health care
7.2 Siemens healthcare
7.3 GE healthcare
7.4 Shimadzu corporation
7.5 Varian medical systems
7.6 Identafi
7.7 AdDent, Inc.
7.8 Velscope VX
8. Europe Head and Neck Cancer Diagnostics Market – Competitive Landscape
8.1 Market Share Analysis
8.2 Strategies Adopted by top companies
8.3 Mergers, Acquisitions, Collaborations & Agreements
9. Market Insights
9.1 Industry Experts Insights
9.2 Analysts Opinions
9.3 Investment Opportunities
10. Appendix
10.1 List of figures
10.2 List of figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.